๐Ÿ‡ฎ๐Ÿ‡ชIreland
16ยฐC Partly Cloudy ยท Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Hangzhou
Clinical trial register · China

Clinical Trials in Hangzhou, 2026

Every study on the ClinicalTrials.gov registry that lists a site in China and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage โ€” all 19052 matching records held by the registry are in this view. Synced 22 Sep 2026, 11:10 UTC
19052
Studies in scope
all four open statuses
11786
Recruiting now
open to new participants
2009
Lead sponsors
across recruiting studies
Top sites
Beijing 5484 Shanghai 3827 Guangzhou 3318 Hangzhou 1812 Wuhan 1343
Narrow the registerReset
Recruitment status
Phase
Lead sponsor
Second Affiliated Hospital, Zhejiang University, School of Medicine373 Zhejiang University104 First Affiliated Hospital of Zhejiang University103 AstraZeneca76 Zhejiang Cancer Hospital63
Site location
Beijing5484 Shanghai3827 Guangzhou3318 Hangzhou1812 Wuhan1343
All 613 locations
Target enrolment
to

Trials with a site in Hangzhou

1812 of 19052 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Chinese sites
Start
Recruiting
Effects of TDCS Intervention on Neoadjuvant Chemotherapy in Breast Cancer Patients with Mild to Moderate Depression
NCT06741540Breast Cancer
Second Affiliated Hospital, Zhejiang University, School of Medicine
Not applicable
60
Hangzhou
2025-01-01
Not yet open
A Clinical Study of SCTC21C in Participants With Plasma Cell-driven Autoimmune Diseases
NCT06774664IgA Nephropathy
Sinocelltech Ltd.
Phase 1/2
99
Baotou, Beijing, Chengdu, Guangzhou, Hangzhou, Jinan, Nanchang, Nanning
2025-01
Not yet open
Sintilimab Combined With Bevacizumab and TP Chemotherapy in the Treatment of High Risk Locally-advanced NPC
NCT06752382Locally Advanced Nasopharyngeal Carcinoma
Zhejiang Cancer Hospital
Phase 2
58
Hangzhou
2024-12-31
Not yet open
Efficacy and Safety of Changkang Granules in the Treatment of Irritable Bowel Syndrome With Predominant Diarrhea (Liver qi Affecting the Spleen Pattern)
NCT06753890Diarrhea-predominant Irritable Boewl Syndrome
Tasly Pharmaceutical Group Co., Ltd
Phase 3
520
Baoding, Beijing, Changsha, Chengde, Chengdu, Guangzhou, Hangzhou, Kaifeng
2024-12-30
Not yet open
Correlation Among Various OLGA and OLGIM Stages, Digestive Symptom Scores, and Acupuncture Treatment in Patients with Chronic Atrophic Gastritis
NCT06707701Chronic Atrophic Gastritis (CAG)
Yi Liang
Observational
400
Hangzhou
2024-12-30
Recruiting
Study of IBI3009 in Participants with Unresectable, Metastatic or Extensive-Stage Small Cell Lung Cancer
NCT06613009Small Cell Lung Cancer
Innovent Biologics (Suzhou) Co. Ltd.
Phase 1
190
Hefei, Fuzhou, Zhengzhou, Changsha, Nanchang, Jinan, Hangzhou
2024-12-30
Not yet open
Clinical Application of 99mTc-FDPH46 SPECT/CT Imaging in Malignant Solid Tumor: a Prospective Exploratory Study
NCT06753513Malignant Tumors, Solid Tumor Malignancy
Zhejiang University
Observational
20
Hangzhou
2024-12-28
Recruiting
Liposomal Irinotecan and Apatinib in ES-SCLC
NCT06749691Small Cell Lung Cancer Extensive Stage
Second Affiliated Hospital, Zhejiang University, School of Medicine
Phase 2
30
Hangzhou
2024-12-28
Recruiting
CDH17 CAR-T Therapy in Advanced Malignant Solid Tumors
NCT06937567Biliary Tract Cancer, Colorectal Carcinoma, Gastric Cancer, Metastatic, Pancreatic Adenocarcinoma (Ductal Adenocarcinoma)
Zhejiang University
Phase EARLY_PHASE1
36
Hangzhou
2024-12-26
Active, closed
Spirulina Tablets Treat Liver Fibrosis/Cirrhosis
NCT06770283Liver Cirrhosis
Second Affiliated Hospital, Zhejiang University, School of Medicine
Not applicable
10
Hangzhou
2024-12-26
Recruiting
Neoadjuvant Toripalimab and Radiotherapy Treatment in N+ HR+ Breast Cancer
NCT06671262Breast Adenocarcinoma
Second Affiliated Hospital, Zhejiang University, School of Medicine
Phase 2
74
Hangzhou
2024-12-26
Recruiting
Assessing Combined SBRT in Breast Cancer Non-Responders to Neoadjuvant Chemotherapy
NCT06596018Breast Adenocarcinoma
Second Affiliated Hospital, Zhejiang University, School of Medicine
Phase 1/2
96
Hangzhou
2024-12-25
Recruiting
A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of RAG-17 in Subjects With Amyotrophic Lateral Sclerosis (ALS) With Superoxide Dismutase Type 1 (SOD1) Gene Mutation
NCT06556394Amyotrophic Lateral Sclerosis
Ractigen Therapeutics.
Phase 1
32
Beijing, Chengdu, Hangzhou
2024-12-24
Recruiting
An Exploratory Study on Gene Methylation Detection of Colorectal Cancer
NCT07033156CRC (Colorectal Cancer), Adenoma Colon
Zhejiang Provincial People's Hospital
Observational
450
Hangzhou
2024-12-24
Recruiting
Safety and Efficacy of Metabolically Armed CD19 CAR-T Cells (Meta10-19) in the Treatment of Moderate to Severe Active SLE Clinical Research
NCT06711146Systemic Lupus Erythematosus
Zhejiang University
Phase EARLY_PHASE1
36
Hangzhou
2024-12-24
Active, closed
Anti-CEACAM5 ADC Precemtabart Tocentecan (M9140) in Chinese Participants With Solid Tumors
NCT06806046Solid Tumors, Colorectal Cancer
Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany
Phase 1
12
Beijing, Guangzhou, Hangzhou
2024-12-20
Recruiting
Exploring the Feasibility of Silk Fibroin Surgical Mesh in Rotator Cuff Tears Repair Enhancement
NCT06766630Rotator Cuff Tear
Weiliang Shen, Ph.D., M.D.
Phase 2/3
20
Hangzhou
2024-12-19
Recruiting
A Study of Belantamab Mafodotin Administered in Combination With Lenalidomide and Dexamethasone (BRd) Versus Daratumumab, Lenalidomide, and Dexamethasone (DRd) in Participants With Newly Diagnosed Multiple Myeloma (NDMM) Who Are Ineligible for Autologous Stem Cell Transplantation (TI-NDMM)
NCT06679101Multiple Myeloma, Newly Diagnosed Multiple Myeloma
GlaxoSmithKline
Phase 3
520
Beijing, Chengdu, Chongqing, Guangzhou, Hangzhou, Nanchang, Nanjing, Shanghai
2024-12-16
Recruiting
Comparing Endoscopic Strictureplasty vs. Balloon Dilation in Crohn's Disease Strictures
NCT06203782Crohn Disease
Second Affiliated Hospital, Zhejiang University, School of Medicine
Not applicable
102
Hangzhou
2024-12-16
Recruiting
Study of BM230 in Patients With Advanced Solid Tumors
NCT06644300Solid Tumor
Suzhou Biomissile Pharmaceuticals Co., Ltd.
Phase 1
123
Bengbu, Shanghai, Hangzhou
2024-12-16
Recruiting
A Randomized Trial Comparing the Efficacy and Safety of Secukinumab with Tofacitinib in the Treatment of Moderate to Severe Hidradenitis Suppurativa in Chinese Patients
NCT06707246Hidradenitis Suppurativa
Second Affiliated Hospital, Zhejiang University, School of Medicine
Not applicable
60
Hangzhou
2024-12-15
Recruiting
Clinical Evaluation of Extended Depth-of-focus Intraocular Lens in Refractive Cataract Surgery: a Randomized Controlled Trial
NCT06658119Cataract
Second Affiliated Hospital, Zhejiang University, School of Medicine
Not applicable
90
Hangzhou
2024-12-15
Recruiting
Universal CNK-UT Therapy for Refractory aGVHD
NCT06750133Acute Graft-versus-Host Disease
First Affiliated Hospital of Zhejiang University
Phase 1
23
Fuzhou, Hangzhou
2024-12-14
Active, closed
Study to Evaluate the Efficacy and Safety of AHB-137 in Treatment-naive Participants With Chronic Hepatitis B (CHB)
NCT06829329Chronic Hepatitis B
Ausper Biopharma Co., Ltd.
Phase 2
105
Chongqing, Fuzhou, Guangzhou, Changzhou, Zhenjiang, Hangzhou
2024-12-13
Active, closed
A Study to Evaluate the Adverse Events, Efficacy, and Optimal Dose of Intravenous (IV) ABBV-400 in Combination With IV Fluorouracil, Leucovorin, and Budigalimab in Adult Participants With Locally Advanced Unresectable or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma
NCT06628310Locally Advanced Unresectable or Metastatic Gastric Adenocarcinoma, Gastroesophageal Junction Adenocarcinoma, Esophageal Adenocarcinoma
AbbVie
Phase 2
185
Beijing, Langfang, Harbin, Wuhan, Hangzhou
2024-12-13
Recruiting
A Study of Amivantamab and FOLFIRI Versus Cetuximab/Bevacizumab and FOLFIRI in Participants With KRAS/NRAS and BRAF Wild-type Colorectal Cancer Who Have Previously Received Chemotherapy
NCT06750094Colorectal Neoplasms
Janssen Research & Development, LLC
Phase 3
700
Beijing, Changchun, Changsha, Chengdu, Ganzhou, Guangzhou, Hangzhou, Harbin
2024-12-12
Recruiting
A Study to Investigate the Long-term Safety and Efficacy of Belimumab in Adults With Interstitial Lung Disease (ILD) Associated With Systemic Sclerosis (SSc) and Other Connective Tissue Diseases (CTD) (BLISSconneCTD-OLE)
NCT06716606Connective Tissue Diseases
GlaxoSmithKline
Phase 3
514
Beijing, Chengdu, Hangzhou, Mianyang, Shanghai, Shenyang, Zhuzhou
2024-12-12
Recruiting
A Phase 3 Efficacy and Safety Study of Fosmanogepix for the Treatment of Adult Participants With Candidemia and/or Invasive Candidiasis.
NCT05421858Candidemia, Candidiasis, Invasive
Basilea Pharmaceutica
Phase 3
450
Beijing, Bengbu, Chengdu, Guangzhou, Hangzhou, Lishui, Liuzhou, Nanchang
2024-12-11
Recruiting
A Study to Assess the Efficacy and Safety of Induction Therapy With Afimkibart (Also Known as RO7790121) in Participants With Moderately to Severely Active Ulcerative Colitis
NCT06588855Moderately to Severely Active Ulcerative Colitis
Hoffmann-La Roche
Phase 3
350
Beijing, Kunming, Changsha, Chengdu, Guangzhou, Hangzhou, Huizhou, Nanchang
2024-12-11
Active, closed
A Study to Investigate Efficacy and Safety of SAR441566 in Patients With Crohn's Disease.
NCT06637631Crohn's Disease
Sanofi
Phase 2
260
Changzhou, Chongqing, Fuzhou, Guangzhou, Hangzhou, Hefei, Nanchang, Shanghai
2024-12-10
Recruiting
Blinatumomab in Refractory Active Childhood Systemic Lupus Erythematosus
NCT06789107Systemic Lupus Erythematosus (SLE), Children, Blinatumomab
Mao Jianhua
Phase 1
6
Hangzhou
2024-12-08
Recruiting
Postoperative Analgesia Between Paravertebral Block and Epidural Block in Esophageal Surgery
NCT06704698Pain Syndrome, Dizziness, Vomiting, Itching
Zhejiang Cancer Hospital
Not applicable
132
Hangzhou
2024-12-03
Recruiting
Neoadjuvant Chemotherapy Plus Pyrotinib and Trastuzumab for HER2-positive Breast Cancer (NEOTORCH-BREAST05)
NCT06832904HER2-positive Breast Cancer, Neoadjuvant Therapy, Pyrotinib
First Affiliated Hospital of Zhejiang University
Phase 2
33
Hangzhou
2024-12-03
Recruiting
The Application of Eye-Tracking Technology in Perioperative Management and Education
NCT06766539Eye-tracking Technology, Medical Education, Perioperative Management, Attention Distribution
Second Affiliated Hospital, Zhejiang University, School of Medicine
Observational
300
Hangzhou
2024-12-01
Recruiting
Clinical Study of Cord Blood-derived IL-10/IL-15 CD19-CAR NK in the Treatment of Refractory/Relapsed B-cell NHL
NCT06707259B-cell Non Hodgkin Lymphoma
Second Affiliated Hospital, Zhejiang University, School of Medicine
Phase 1
24
Hangzhou
2024-12-01
Recruiting
A Prospective Study of ยนโธF-DFA PET Imaging for the Assessment of Liver Injury
NCT07050550Liver Injury
First Affiliated Hospital of Zhejiang University
Observational
45
Hangzhou
2024-12-01
By invitation
Risk Model for Metastasis Detection of Neuroblastoma
NCT06703944Neuroblastoma (NB), Prognosis, Bone Marrow Metastasis, Bone Metastases
Xinhua Hospital, Shanghai Jiao Tong University School of Medicine
Observational
500
Shanghai, Hangzhou, Shenzhen
2024-12-01
Recruiting
Safety and Efficacy of Metabolically Armed CD19 CAR-T Cells (Meta10-19) in the Treatment of r/r B-NHL Clinical Research
NCT06716164Non-hodgkin Lymphoma,B Cell
Zhejiang University
Phase EARLY_PHASE1
36
Hangzhou
2024-12-01
Recruiting
CD70-CAR-NK Cell Therapy for T Cell Lymphoma and Acute Myeloid Leukemia
NCT06696846Relapsed/Refractory T-cell Lymphoma, Relapsed/Refractory Acute Myeloid Leukemia
Second Affiliated Hospital, Zhejiang University, School of Medicine
Phase 1
25
Hangzhou
2024-12-01
Recruiting
Diagnosis Value of Interoceptive EEG Indicators by Rectal Stimulation in DoC
NCT07208942Disorders of Consciousness
YiLin Zhao
Observational
45
Hefei, Hangzhou
2024-12-01
Not yet open
Predicting Treatment Failure in HSIL Patients with Positive Margins After Conization Via Detection of PAX1 Methylation
NCT06713655High-grade Squamous Intraepithelial Lesions (HSIL), Cervical Conization
Women's Hospital School Of Medicine Zhejiang University
Observational
800
Hangzhou
2024-12
Recruiting
Effect of Specific Mode Electroacupuncture Stimulation Combined with NGF on Dysphagia After Ischaemic Stroke: a Pilot Randomized Controlled Trial
NCT06737549Ischemic Stroke, Dysphagia
The Third Affiliated hospital of Zhejiang Chinese Medical University
Phase 4
144
Hangzhou
2024-12
Not yet open
The Effectiveness of Pharmaceutical Service for INPATDRP
NCT06674512Drug Related Problem
Zhejiang Provincial People's Hospital
Not applicable
220
Hangzhou
2024-12
Recruiting
Venetoclax Combined With Olverembatinib and Predinisone in Treating Ph+ B-ALL
NCT06754267Precursor B-Cell Acute Lymphoblastic Leukemia
First Affiliated Hospital of Zhejiang University
Phase 2
36
Hangzhou
2024-12
Recruiting
VHAG in Treating R/R T-ALL/LBL
NCT06742463Acute T Lymphpblastic Leukemia/Lymphoma
First Affiliated Hospital of Zhejiang University
Phase 2
50
Hangzhou
2024-12
Recruiting
Targeted Resection of Axillary Metastatic Lymph Nodes After Breast Cancer Neoadjuvant Chemotherapy
NCT04744506Breast Cancer, Surgery, Lymph Node Metastases
Second Affiliated Hospital, Zhejiang University, School of Medicine
Not applicable
126
Hangzhou
2024-11-30
Recruiting
Phase III Study of Socazolimab as First-Line Treatment in Persistent, Recurrent, or Metastatic Cervical Cancer
NCT06459687Cervical Cancer
Lee's Pharmaceutical Limited
Phase 3
440
Hefei, Beijing, Wuhan, Changsha, Hangzhou
2024-11-28
Active, closed
A Phase III Study in Subjects With Primary Open Angle Glaucoma or Ocular Hypertension in China
NCT06666855Open Angle Glaucoma, Ocular Hypertension
Santen Pharmaceutical Co., Ltd.
Phase 3
345
Beijing, Guangzhou, Guiyang, Hangzhou, Heilongjiang, Jinan, Lanzhou, Luoyang
2024-11-28
Recruiting
Study on the Application of Intraoperative Optical Coherence Tomography Technique in the Diagnosis and Treatment of Lens Diseases
NCT06687356Lens Diseases
Second Affiliated Hospital, Zhejiang University, School of Medicine
Not applicable
600
Hangzhou
2024-11-27
Recruiting
A Global Phase III Study of Rilvegostomig or Pembrolizumab Plus Chemotherapy for First-Line Treatment of Locally Advanced or Metastatic Non-Squamous NSCLC
NCT06627647Non-squamous Non-small Cell Lung Cancer
AstraZeneca
Phase 3
1,160
Beijing, Changchun, Changsha, Chengdu, Chongqing, Fuzhou, Guangzhou, Hangzhou
2024-11-27
Recruiting
A Study to Investigate Safety and Effectiveness of Tacabrutideg (BGB-16673) in Combination With Other Agents in Participants With Relapsed or Refractory B-Cell Malignancies
NCT06634589B-cell Malignancy, Relapsed Cancer, Refractory Cancer, B-cell Lymphoma
BeOne Medicines
Phase 1/2
80
Fuzhou, Guangzhou, Suzhou, Hangzhou, Wenzhou
2024-11-27
Recruiting
The Changes Under Different Accommodation of Anterior Eye and 3D Crystal Reconstruction.
NCT06704503Accommodation
Second Affiliated Hospital, Zhejiang University, School of Medicine
Observational
120
Hangzhou
2024-11-27
Recruiting
Pharmacokinetic Study of Tranexamic Acid
NCT06728670Ovarian Neoplasm Epithelial
Zhejiang Cancer Hospital
Not applicable
30
Hangzhou
2024-11-20
Not yet open
A Cluster Randomized Controlled Trial to Compare the Rate of Antibiotic Infusion
NCT06620341Acute Upper Respiratory Tract Infection, Bacterial Infections
Second Affiliated Hospital, Zhejiang University, School of Medicine
Not applicable
11,900
Hangzhou
2024-11-18
Recruiting
Bortezomib Combined with PD-1 MAb and MFOLFIRINOX for Metastatic Pancreatic Cancer
NCT06572813Pancreas Cancer
First Affiliated Hospital of Zhejiang University
Phase 1/2
63
Hangzhou
2024-11-15
Recruiting
Study of Adjuvant Nimotuzumab Combined with Nab-paclitaxel+ Gemcitabine in EGFR-positive Pancreatic Cancer
NCT06722911Pancreatic Cancer Resectable
Zhejiang Provincial People's Hospital
Phase 2
57
Hangzhou
2024-11-15
Active, closed
A Study to Investigate Sonrotoclax Combined With Zanubrutinib Versus Zanubrutinib Alone in Participants With Previously Untreated Chronic Lymphocytic Leukemia
NCT06637501Chronic Lymphocytic Leukemia
BeOne Medicines
Phase 2
94
Fuzhou, Zhengzhou, Changzhou, Nanjing, Shanghai, Hangzhou
2024-11-14
Not yet open
Irinotecan Liposomes +5-FU/LV Versus Capecitabine in Patients of Recurrence After Resection of Resectable BTC
NCT06699459Biliary Tract Carcinoma
Sir Run Run Shaw Hospital
Phase 2
76
Fuzhou, Guangzhou, Shanghai, Hangzhou
2024-11-14
Active, closed
An Observational, Prospective, Multicenter Study to Evaluate the Biologic Use and Outcomes in Chinese Asthma Patients
NCT06605885Asthma
AstraZeneca
Observational
202
Hohhot, Beijing, Changsha, Chengdu, Foshan, Fuzhou, Guangzhou, Hangzhou
2024-11-14
Active, closed
Efficacy of Home-based Treatment for Breast Cancer-related Lymphedema
NCT06783543Lymphedema Arm
Second Affiliated Hospital, Zhejiang University, School of Medicine
Not applicable
40
Hangzhou
2024-11-13
Recruiting
Clinical Study of Second-line Treatment in Advanced Colorectal Cancer With Chemotherapy With Bevacizumab or Cetuximab
NCT06540326Colorectal Cancer Metastatic
Second Affiliated Hospital, Zhejiang University, School of Medicine
Phase 2
100
Hangzhou
2024-11-12
Recruiting
Clinical Study of CD19 Targeted Universal Chimeric Antigen Receptor T Lymphocytes (UCAR-T) for the Treatment of Refractory Juvenile Dermatomyositis (RJDM)
NCT06686524Dermatomyositis, Juvenile, Dermatomyositis
Chongqing Precision Biotech Co., Ltd
Phase 1
18
Hangzhou
2024-11-11
Not yet open
Effect of an Oral Frailty Measures Intervention Programs in Institutionalized Elders
NCT06536985Frailty
Hangzhou Normal University
Not applicable
226
Hangzhou
2024-11-11
Recruiting
Electroacupuncture Regulation of Immune Cells in Herpes Zoster
NCT06643247Herpes Zoster, Electroacupuncture, Immune
First People's Hospital of Hangzhou
Not applicable
8
Hangzhou
2024-11-11
Active, closed
Effect of Perioperative Roxadustat in Elective Lumbar Interbody Fusion Surgery.
NCT06772272Perioperative Anemia
Second Affiliated Hospital, Zhejiang University, School of Medicine
Phase 3
158
Hangzhou
2024-11-10
Recruiting
Drug Sensitivity of Hydrothorax and Ascite Organoids from Breast Cancer
NCT06658080Breast Cancer Metastatic, Hydrothorax, Ascites, Organoids
Second Affiliated Hospital, Zhejiang University, School of Medicine
Observational
90
Hangzhou
2024-11-09
Recruiting
A Study of RNK08954 in Subjects With Advanced Solid Tumors With KRAS ((Kirsten Rat Sarcoma) G12D Mutation
NCT06667544KRAS G12D Mutation
Ranok Therapeutics (Hangzhou) Co., Ltd.
Phase 1/2
152
Nanning, Zhengzhou, Wuhan, Hangzhou, Shanghai
2024-11-08
Active, closed
Study of Lunsekimig (SAR443765) Compared With Placebo in Adults With High-risk Asthma
NCT06676319Asthma
Sanofi
Phase 2
556
Beijing, Changchun, Chengde, Chengdu, Foshan, Guangzhou, Guiyang, Hangzhou
2024-11-07
Recruiting
89Zr-TLX250 for PET/CT Imaging of ccRCC - ZIRCON-CP Study
NCT06750419Clear Cell Renal Cell Carcinoma
Telix Pharmaceuticals (Innovations) Pty Limited
Phase 3
82
Beijing, Hangzhou, Hubei, Shanghai, Suzhou, Tianjin, Wuxi, Zhejiang
2024-11-06
Recruiting
RLC Followed by CR-CHOP in Elderly Patients with Newly-diagnosed DEL
NCT06674096Double-expressor Lymphoma
Zhejiang Cancer Hospital
Phase 2
44
Hangzhou
2024-11-06
Recruiting
A Phase I Study of CFT8919 in Patients With Advanced NSCLC
NCT06641609Non-Small Cell Lung Cancer With EGFR Mutation
Betta Pharmaceuticals Co., Ltd.
Phase 1
166
Hangzhou
2024-11-04
Recruiting
Clinical Trial of WBC100 Capsule in Relapsed/Refractory Acute Myeloid Leukemia
NCT07014449AML (Acute Myelogenous Leukemia, Relapsed Acute Myelogenous Leukemia, Refractory Acute Myeloid Leukemia, Hematologic Malignancy
Hangzhou Weben Pharma Co., Ltd
Phase 1
18
Hangzhou
2024-11-03
By invitation
Evaluation of Endoscopic Treatment Effect Based on HVPG
NCT06863519Esophageal and Gastric Varices
Second Affiliated Hospital, Zhejiang University, School of Medicine
Observational
50
Hangzhou
2024-11-01
Not yet open
Abnormal Glucose Tolerance in Allogeneic Hematopoietic Stem Cell Transplantation
NCT06704542ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION, Diabetes Mellitus, Impaired Fasting Glucose
Ruijin Hospital
Observational
1,000
Zhengzhou, Wuhan, Shanghai, Hangzhou, Tianjin
2024-11
Not yet open
Identification Of High-risk Coronary Plaques By Multimodal Intravascular Imaging
NCT06681155Coronary Arterial Disease (CAD), Acute Coronary Syndromes
Chinese PLA General Hospital
Observational
500
Shenzhen, Wuhan, Changchun, Xi'an, รœrรผmqi, Hangzhou, Beijing
2024-11
Not yet open
A Clinical Trial to Evaluate the Safety and Tolerability of TQB3911 Tablets in Patients With BCR::ABL Fusion Gene Positive Leukemia
NCT06672263Chronic Myelogenous Leukemia
Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd.
Phase 1
120
Beijing, Nanning, Zhengzhou, Shanghai, Hangzhou
2024-11
Not yet open
Study to Assess the Efficacy and Safety of Meropenem and Pralurbactam in CIAI
NCT06633718Intra-abdominal Infections
Qilu Pharmaceutical Co., Ltd.
Phase 3
786
Hangzhou
2024-10-31
Recruiting
A Study to Evaluate the Efficacy and Safety of Combination Therapy of BRII-179, BRII-835 and PEG-IFNฮฑ in Participants With Chronic Hepatitis B Virus (HBV) Infection (ENHANCE)
NCT06650852Chronic Hepatitis B Virus (HBV) Infection
Brii Biosciences Limited
Phase 2
250
Beijing, Guangzhou, Shenzhen, Shanghai, Chengdu, Hangzhou
2024-10-31
Recruiting
Efficacy and Safety of CD19 UCAR T Cells in Refractory Systemic Lupus Erythematosus
NCT06691152Systemic Lupus Erythematosus
The Children's Hospital of Zhejiang University School of Medicine
Phase 1
18
Hangzhou
2024-10-30
Recruiting
Multicenter iTBS Neuromodulation for PTSD Treatment
NCT06434766Posttraumatic Stress Disorder
Second Affiliated Hospital, Zhejiang University, School of Medicine
Not applicable
140
Shanghai, Hangzhou, Ningbo
2024-10-30
Active, closed
A Study of Valemetostat Tosylate Plus Pembrolizumab Versus Pembrolizumab Alone in First-Line NSCLC Without Actionable Genomic Alterations
NCT06644768Non-small Cell Lung Cancer, Lung Cancer
Daiichi Sankyo
Phase 1/2
137
Changchun, Hangzhou, Harbin, Jiamusi, Shanghai, Tiyuan, Zhengzhou
2024-10-30
Recruiting
Neoadjuvant Radiotherapy for Locally Advanced Unresectable Thymoma
NCT06924619Locally Advanced Thymoma
Second Affiliated Hospital, Zhejiang University, School of Medicine
Phase 2
178
Hangzhou
2024-10-30
Recruiting
Clinical Application Comparison of Two Femtosecond Laser Systems
NCT06754358Cataract
Second Affiliated Hospital, Zhejiang University, School of Medicine
Phase 1
100
Hangzhou
2024-10-29
Recruiting
A Long-term Extension (LTE) Study of Guselkumab in Pediatric Participants
NCT06663332Crohns Disease, Colitis, Ulcerative, Arthritis, Psoriatic, Arthritis, Juvenile
Janssen Research & Development, LLC
Phase 3
196
Beijing, Changzhou, Hangzhou, Shanghai, Shenyang
2024-10-29
Not yet open
Vaccine Chatbot for Improving Influenza Vaccination Uptake
NCT06657573Influenza Vaccines
Fudan University
Not applicable
1,200
Hangzhou
2024-10-26
Not yet open
Comparing the Safety and Cosmetic Outcomes Between Laparoscopic Versus Traditional Open Breast-conserving Surgery
NCT06671249Breast Cancer
Second Affiliated Hospital, Zhejiang University, School of Medicine
Not applicable
184
Hangzhou
2024-10-25
Recruiting
Benmelstobart Combined With Radiochemotherapy as Neoadjuvant Treatment Iin ESCC
NCT06637163Esophageal Squamous Cell Carcinoma
Shanghai Zhongshan Hospital
Phase 2
100
Shantou, Shenyang, Shanghai, Tianjin, Hangzhou
2024-10-24
Recruiting
A Study of OL-101 Injection in Patients with Relapsed or Refractory Multiple Myeloma (RRMM)
NCT06644118Multiple Myeloma
Zhejiang University
Phase 1
58
Beijing, Xiโ€™an, Hangzhou
2024-10-23
Recruiting
Targeting CD5 CAR-T Cells in the Treatment of r/r CD5+ T-lymphoma
NCT06633341T-lymphoblastic Lymphoma
Zhejiang University
Phase EARLY_PHASE1
30
Hangzhou
2024-10-20
Recruiting
Targeting CD5 CAR-T Cells in the Treatment of r/r CD5+ T-ALL
NCT06633354T-Acute Lymphoblastic Leukemia
Zhejiang University
Phase EARLY_PHASE1
30
Hangzhou
2024-10-20
Recruiting
Prevention of Recurrence and Metastasis of Colorectal Cancer by Comparing Huaier With Capecitabine Monotherapy
NCT06090994Colorectal Cancer
Fudan University
Phase 4
756
Harbin, Changzhou, Nanjing, Yangzhou, Shanghai, Hangzhou, Ningbo
2024-10-18
Recruiting
A Study of Amivantamab and mFOLFOX6 or FOLFIRI Versus Cetuximab and mFOLFOX6 or FOLFIRI as First-line Treatment in Participants With KRAS/NRAS and BRAF Wild-type Unresectable or Metastatic Left-sided Colorectal Cancer
NCT06662786Colorectal Neoplasms
Janssen Research & Development, LLC
Phase 3
1,000
Beijing, Changchun, Changsha, Guangzhou, Hangzhou, Harbin, Huizhou, Nanchang
2024-10-18
Recruiting
Application of CIELab Spectrophotometry to Analyze Gingival Color: a New Perspective for Evaluating the Effectiveness of Periodontal Basic Treatment
NCT06698718Periodontitis
Second Affiliated Hospital, Zhejiang University, School of Medicine
Not applicable
30
Hangzhou
2024-10-18
Recruiting
Blinatumomab Plus Reduced-dose Chemotherapy in Treating B-ALL
NCT06742515Precursor B-Cell Acute Lymphoblastic Leukemia
First Affiliated Hospital of Zhejiang University
Phase 2
20
Hangzhou
2024-10-17
Active, closed
A Study of Dostarlimab in Participants With Untreated Locally Advanced Rectal Cancer in China
NCT06640049Neoplasms, Rectal
GlaxoSmithKline
Phase 2
23
Chengdu, Chongqing, Guangzhou, Hangzhou, Jinan, Kunming, Shanghai
2024-10-17
Not yet open
An IIT Clinical Study to Evaluate the Safety, Tolerability, and Preliminary Efficacy of a Single Intrathecal Injection of SNUG01 in Patients with Amyotrophic Lateral Sclerosis
NCT06645197Amyotrophic Lateral Sclerosis (ALS)
Peking University Third Hospital
Phase EARLY_PHASE1
7
Beijing, Fujian, Nanjing, Chengdu, Hangzhou
2024-10-16
Recruiting
Evaluate the Safety and Preliminary Efficacy of EXG110 in Subjects With Fabry Disease
NCT06539624Fabry Disease
The Children's Hospital of Zhejiang University School of Medicine
Not applicable
12
Shanghai, Hangzhou
2024-10-16
Recruiting
Safety and Effectiveness Evaluation of Spinal Laminectomy Robot
NCT06593574Lumbar Spinal Stenosis, Lumbar Disc Herniation
Peking University Third Hospital
Not applicable
70
Beijing, Guangzhou, Hangzhou
2024-10-15
Recruiting
Study of IBI363 in Patients with Advanced First-line Gastric Cancer
NCT06610799IBI363 + Chemotherapy
Xiangdong Cheng
Phase 1
40
Hangzhou
2024-10-15
Recruiting
Anti-Mesothelin CAR-T Cell Injection in Patients With Mesothelin-positive Advanced Malignant Solid Tumors
NCT07010523Mesothelin-positive Advanced Malignant Solid Tumors
First Affiliated Hospital of Zhejiang University
Not applicable
24
Hangzhou
2024-10-15
Rows per page Showing 901–1000 of 1812
Previous 8 9 10 11 12 Next
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Chinese investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 24 September 2026. https://priyalifescience.com/clinical-trials-china/city/hangzhou?page=10

Query this register directly
GET /api/trials?country=cn&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in China and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 19,052 studies in total at the last sync on 22 Sep 2026, 11:10 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 1,812 of those studies with a site in Hangzhou.

How many clinical trials are recruiting in Hangzhou?

1,096 of the 1,812 studies on this page are recruiting new participants as of the 22 Sep 2026, 11:10 UTC sync. A further 300 have not yet opened recruitment, 372 are active but closed to new participants, and 44 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and India registers.